171 filings
Page 3 of 9
8-K
s4gnyi5mpu fur6
11 May 22
Trevena Reports First Quarter 2022 Results and Provides
7:05am
8-K
dbnzl dqzxtedh
25 Apr 22
Other Events
7:01am
8-K
y1kwvihj4li 5l51pj0
20 Apr 22
Regulation FD Disclosure
5:11pm
8-K
rn4uu n0mhxinbp
20 Apr 22
Trevena Announces Results from Respiratory Physiology Study of Head-to-Head Comparison of OLINVYK® and IV Morphine in Elderly/Overweight Subjects
8:59am
8-K
ukcq pk1dcuvmruczf
31 Mar 22
Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing
7:05am
8-K
ah2vj
31 Mar 22
Trevena Reports Fourth Quarter and Full Year 2021 Results
7:04am
8-K
3ziw4xb5 ek
27 Jan 22
Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu Nhwa Pharmaceutical
9:04am
8-K
wrolresrtb
23 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
copmdy7u7sszenq5 0k
15 Nov 21
Trevena Reports Third Quarter 2021 Results
9:24pm
8-K
he9gybpivdsmrrl zt
4 Oct 21
Other Events
6:02am
8-K
9anrjui n18ws0zw1ua
7 Sep 21
Other Events
4:05pm
8-K
nzcc1m
12 Aug 21
Trevena Reports Second Quarter 2021 Results
8:02am
8-K
08czd
4 Aug 21
Other Events
4:04pm
8-K
ikn8k1sv
16 Jun 21
Regulation FD Disclosure
4:08pm
8-K
nbjbjv9wtam6
28 May 21
Other Events
5:23pm
8-K
7dmha72eg37 rdsw
14 May 21
Submission of Matters to a Vote of Security Holders
4:17pm
8-K
zd98y4skd bdpcar9sl
6 May 21
Trevena Reports First Quarter 2021 Results
7:05am
8-K
van0o6xh ayi5o8
21 Apr 21
Regulation FD Disclosure
7:05am
8-K
l03wm 7ohz
18 Mar 21
Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors
7:01am
8-K
q0spuy9twhv1
9 Mar 21
Trevena, Inc. Reports Fourth Quarter and Full Year 2020 Results
7:02am